Compare Neurocrine Biosciences Inc (NBIX) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Neurocrine Biosciences Inc trades at $142.44 (market cap $14.36B), while Vanguard Real Estate Index Fund ETF trades at $90.65 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 4.9× Neurocrine Biosciences Inc's market cap, and Vanguard Real Estate Index Fund ETF is more actively traded (6,073,580 versus 1,237,180). Which is the better fit depends on your goals — on Pluang, investors hold Neurocrine Biosciences Inc for 23 Days and Vanguard Real Estate Index Fund ETF for 113 Days on average.
| NBIX | VNQ | |
|---|---|---|
Market Cap | $14.36B | $70.80B |
Volume | 1,237,180 | 6,073,580 |
Sector | Health | — |
52-Week High | $185.50 | $100.95 |
52-Week Low | $123.10 | $87.00 |
Typical Hold Time | 23 Days | 113 Days |
Enterprise Value | $14.37B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $141.25, down 1.55% on the day, with a bearish technical signal driven by moving averages. Fundamentally, the company shows strong profitability with a 20.91% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights pipeline progress in Prader-Willi syndrome and executive appointments.
The outlook is supported by robust analyst consensus (86.49% buy ratings) and a $204.18 price target, but risks include execution of pipeline diversification and potential pricing pressure on key drug Ingrezza. The stock offers growth potential from expanding rare-disease assets, contingent on successful commercialization.
VNQ trades at $89.35, up 0.74% today, but faces bearish technical signals with moving averages indicating selling pressure. The ETF has declined nearly 10% recently amid rising Treasury yields and Fed rate hikes, eroding its income appeal versus safer alternatives. Recent institutional buying by State Street Corp and Envestnet suggests some see value at current levels, while news highlights sector headwinds from interest rate sensitivity and oversupply concerns in certain real estate segments.
Outlook remains challenged by rising rates compressing REIT valuations, though contrarian investors see opportunity in discounted sector exposure. Key risks include prolonged high interest rates, economic slowdown impacting property demand, and competition from Treasury yields. The dividend yield advantage has narrowed significantly, requiring careful assessment of total return potential versus rate-sensitive alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
